Pharmacological treatment of angina Flashcards

1
Q

What is the window for coronary flow in the heart

A

Where the aortic pressure is greater than ventricular pressure (coronary arteries are compressed in systole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What shrinks the window for coronary blood flow?

A

• Shortening diastole
– e.g. increased heart rate

• Increased ventricular end diastolic pressure
– e.g. aortic valve stenosis

• Reduced diastolic arterial pressure
– e.g. mitral or aortic valve incompetence, heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss coronary ischaemia and infarction

A

• Coronary ischaemia usually the result of atherosclerosis
– Causes angina
• Sudden ischaemia is usually caused by thrombosis
– May result in cardiac infarction
• Coronary spasms sometimes causes angina
– “variant” angina
• Cellular calcium overload results from ischaemia
– may cause cell death and dysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss angina pectoris

A

• Chest pain due to inadequate supply of oxygen to the heart
– Typically severe and crushing
– “Tight, constricting, dull or heavy”
–SIGN Guidelines

• Characteristic distribution of pain
– Often retrosternal, or left side of chest and can radiate to left arm, neck, jaw and back
– Brought on by exertion, cold or excitement
– Thought chemical factors that cause pain in skeletal muscle (i.eK+,H+ and adenosine) are responsible

• Angina can accompany or be a precursor of a heart attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three classes of angina and what type of ischaemia are they associated with

A

Printzmetal’s variant angina (vasospasm)
- Supply ischaemia

Chronic stable angina (fixed stenosis)
-Demand ischaemia

Unstable angina (thrombus)
-Supply ischaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discus the angina classes

A

• Stable Angina
– Predictable chest pain on exertion
– Caused by a fixed narrowing of the coronary arteries

• Unstable Angina
– Occurs at rest and with less exertion than stable angina
– Associated with a thrombus around a ruptured atheromatous plaque
but without complete occlusion of the vessel (similar to MI)

• Variant (Prinzmetal) Angina
– Uncommon
– Caused by coronary artery spasm
– Not completely understood, but sometimes associated with atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some treatments to reduce chest pain symptoms?

A
– Beta-blockers
– Nitrates
– Calcium channel antagonists
– Nirocandil (K+ channel activator)
– Ivabradine (HCN Channel blocker)
– Ranolazine (fatty acid oxygenation inhibitor(?))

(Don’t need to know brackets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some treatments to prolong survival in those with angina

A

– Beta-blockers
– Aspirin
– Statins
– (Angiotensin Converting Enzyme Inhibitors)
– (AngiotensinII Receptor Blockers) - (ACEI or ARBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you treat symptoms of angina

A

• Offer short-acting nitrate for preventing/treating episodes of angina.

• Offer first-line treatment:
– Usually a β-blocker, but a calcium channel blocker (CCB)
can be considered.

  • If control by β-blockers not optimal, addition of CCB can be considered.
  • If beta blocker or CCB monotherapy ineffective and the other option is contraindicated, there are a few other drugs may be additionally used (e.g. nicorandil or ivabradine).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a short acting nitrate

A

Glyceryl trinitrate (GTN) tablets/spray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do antianginal drugs work?

A

• Mainly work by ↓ the metabolic demand of the muscle

• Organic nitrates, nicorandil and calcium antagonists are vasodilators
– ↓ preload or afterload

• b-blockers and ivabradine slow down the heart
– ↓ the metabolic demand of the muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss organic nitrates

A

• Glyceryl trinitrate and isosorbide mononitrate
– Powerful vasodilators

– Work by being metabolised to nitric oxide (NO) and relax smooth muscle (particular vascular smooth muscle)

– Act on veins to ↓ cardiac preload
• Higher concentrations can affect arteries, therefore ↓afterload

– ↓ cardiac workload is helped by dilaIon of collateral coronary vessels
• therefore improves distribution of coronary blood flow towards ischaemic areas
• Dilation of constricted coronary vessels is particularly beneficial in variant angina
(basically increases flow in arteries that bypass og)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss clinical uses of organic nitrates in angina

A

• Stable Angina
– Prevention by sublingual glyceryl trinitrate shortly before
exertion or isosorbide mononitrate long before

• Unstable angina
– intravenous glyceryl trinitrate (GTN)

• Unwanted effects are common, headache and postural hypotension may occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some other uses of organic nitrates (not angina)

A

• Acute heart failure (in specific circumstances)
– intravenous GTN

• Chronic Heart Failure (CHF)
– isosorbide mononitrate with hydralazine in patients of African origin especially, (or patient cannot tolerate more commonly used CHF drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss b(beta)-blockers

A
  • Important (first line treatment) in the prophylaxis and treatment of stable and unstable angina
  • ↓cardiac oxygen consumption by slowing the heart
  • Also have an antidysrhythmic action – reduce death after MI
  • Bisoprolol, Atenolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss calcium channel blockers (CCBs)

A

• Preventing opening of voltage-gated L-type Ca2+ channels
– Therefore block Ca2+ entry
– Mainly affect the heart and smooth muscle to inhibit calcium entry upon muscle cell depolarisation

• Two main types:
– Dihydropyridine derivatives, e.g. amlodipine and lercanidipine
– Rate-limiting, e.g. verapamil and diltiazem

• Vasodilator effect mainly on resistance vessels
– Therefore reduces afterload
– also dilate coronary vessels (important in variant angina)

• Verapamil and diltiazem can reduce and impair AV conduction and myocardial contractility

17
Q

What are the clinical uses of calcium channel blockers (CCBs) in angina

A

• Choice depends on comorbidity and drug interactions
– Amlodipine or lercanidipine safe in patients with heart failure, used instead of a Beta-Blocker in Prinzmetal angina or alongside beta-blockers in most angina
– Diltiazem or verapamil used but contraindicated in heart failure, bradycardia, AV block or in presence of Beta-Blocker

• Side effects include:
– headache, constipation, ankle oedema

18
Q

What are some other (not angina) uses of CCBs?

A

• Antidysrhythmics
– Mainly verapamil
• Slows ventricular rate in rapid atrial fibrillation
• Prevents recurrence of supraventricular tachycardia (SVT)
• No effect on ventricular arrhythmias

• Hypertension
– Mainly amlodipine or lercanidipine

19
Q

Discuss potassium channel activators

A

• Nicorandil
– combines activation of potassium K+ATP channels
with nitrovasodilator actions
• Causes hyperpolarisation of vascular smooth muscle
– both an arterial and venous dilator
– causes headaches, flushing and dizziness
– used for patients who remain symptomatic despite optimal management with other drugs

20
Q

What are some other anti-anginals that don’t fall into the discussed categories

A

• Ivabradine
– Inhibits funny “f”-type channels in heart
– Reduces cardiac pacemaker activity
• Therefore inhibits heart rate

• Ranolazine
– Unique anti-anginal used as a last resort

21
Q

Learning outcomes

A

Explain the pathology underlying the different categories of angina.
Categorise the drugs used to treat the symptoms of angina and those that prolong survival.
Relate the mechanism of action of drugs to used to treat the symptoms of angina to their therapeutic outcome and side-effects.